September 17, 2026
Sling Therapeutics
Sling Therapeutics is an Ann Arbor-based clinical-stage biopharmaceutical company focused on advancing an oral drug for Thyroid Eye Disease.
- Round
- Series C
- Amount raised
- $123M
- Lead investor
- —
- Industry
- Biotechnology, Pharmaceuticals
- Headquarters
- Ann Arbor
- Employees
- —
- Website
- —
- —
Source: Google Alerts